Renalytix raises $1M in registered direct offering at $0.375/share, with option for up to $3.9M

Renalytix plc

Issued 2,666,667 ordinary shares at $0.375 each for gross proceeds of approximately $1.0 million.
Investor has option until April 17, 2024 to purchase up to 7,811,696 additional shares at same price, potentially raising $3.9M total.
Initial closing expected April 11, 2024; subsequent tranche closing by April 19, 2024 if option exercised.
Offering made under effective shelf registration statement on Form S-3 (File No. 333-274733).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.